CAS: 37076-68-9; (R)-5-Fluoro-1-(Tetrahydrofuran-2-yl)Pyrimidine-2,4(1H,3H)-Dione

该化合物是氟虫胺衍生物,其特点是其N1位置的有机氧化物(ttra hydriffuran)替代物.该复合物作为制药合成的多用途中间体,特别是核分子类比和抗病毒剂的潜力.氟虫原子的存在加强了代谢稳定性和结合性,而2R-oxolan-2-yl组则促进了立体选择性互动.其硬性四氢基-2,4-done核心为进一步的功能化提供了稳定的骨架.该复合物对于医药化学研究来说,表明在开发有针对性的治疗方法方面很有用处,利用其独特的结构特征来改善药用植物特性.

结构式图片

上下游产品

CAS号68723-23-9 dehydroftorafur

合成工艺路线路线简述

    📜去氢替加氟 反应生成替加氟
    参考文献:Novel Ester Precursor Intermediates And Antipodes For The Preparation Of
    标题:Novel Ester Precursor Intermediates And Antipodes For The Preparation Of
    摘要:本公开涉及一种一般式化合物:##str1## 以及该化合物的新对映体.

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-12391691-B2
    优先权日:2018-11-16
    标题:Synthesis of key intermediate of KRAS G12C inhibitor compound
    发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY
    权利人:AMGEN INC
    摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as

    专利号:US-2025206736-A1
    优先权日:2019-11-14
    标题 :Synthesis of kras g12c inhibitor compound
    发明人:CORBETT MICHAEL THOMAS; CAILLE SEBASTIEN
    权利人:AMGEN INC
    摘要:The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2-isopropyl-4-methylpyridin-3-amine, useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.

    专利号:US-5075446-A
    优先权日:1989-12-29
    标题:Synthesis of tetrahydro-2-furylated pyrimidine derivatives
    发明人:KIM YONG H; LEE CHUN H
    权利人:KOREA ADVANCED INST SCI & TECH
    摘要:The synthesis of 1-(tetrahydro-2-furyl) pyrimidine derivatives in good yields by the reaction of trimethylsilylated pyrimidine bases with 2-acetoxytetrahydrofuran using a catalytic amount of cesium chloride in acetonitrile under mild conditions is described.

    专利号:US-2024209029-A1
    优先权日:2021-04-21
    标题:Adiponectin glycopeptides and compositions and methods of use thereof
    发明人:WANG YU; LI XUECHEN; XU AIMIN; WU HONGXIANG; ZHANG YIWEI; LI YUANXIN
    权利人:UNIV HONG KONG
    摘要:An improved method for the chemical synthesis of glycosylated peptides has been developed. The method uses stereoselective glycan synthesis and chemical peptide ligation to produce glycopeptides at lower-cost and with higher efficiency/yield compared to conventional methods. In particular, a method for the large-scale, chemical synthesis of hydroxylated amino acid building blocks and glycosylated amino acids suitable for solid phase peptide synthesis (SPPS) are disclosed. SPPS-based methods using the glycosylated amino acids to chemically synthesize adiponectin-like peptides are also described. In vivo studies show that the adiponectin mimicking glycopeptides exhibit significant anticancer, anti-obesity and insulin sensitizing effects. Pharmaceutical compositions of the synthetic glycopeptides and methods of use thereof in treating diseases associated with deficient adiponectin are also described.

    专利号:WO-2017100796-A1
    优先权日:2015-12-11
    标 题 :Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
    发明人:WONG CHI-HUEY; HSU TSUI-LING; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI
    权利人:SINACA ACAD; WONG CHI-HUEY; HSU TSUI-LING
    摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta- 4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for disgnostic and therapeutic uses.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Shimane T, Mori T, Ono T, Kaburagi A, Monden T, Furuya A, Kamakazu K, Kobayashi S, Sanbe T, Suzaki H. [Effectiveness of concomitant therapy with S-1, nedaplatin, and radiation for laryngeal cancer]. Gan To Kagaku Ryoho. 2010 Feb;37(2):241–4.
    摘要:Ina K, Hibi S, Furuta R, Takeuchi Y, Nagao S, Kayukawa S, Masaki A, Kataoka T. [Combination therapy of S-1 and 24-h infusion of cisplatin after palliative gastrectomy for stage IV gastric cancer]. Gan To Kagaku Ryoho. 2010 Feb;37(2):251–4.
    摘要:Teshima S, Saito T, Endo A, Yunome G, Harada A, Ooshio H, Kodama H, Takeda K, Kikuchi S. [Problems of adjuvant chemotherapy with S-1 for gastric cancer]. Gan To Kagaku Ryoho. 2010 Feb;37(2):255–8.
    摘要:Taomoto J, Tanabe K, Suzuki T, Hamai Y, Emi M, Hihara J, Yoshida K, Okada M. [Adjuvant surgery for advanced gastric cancer]. Gan To Kagaku Ryoho. 2010 Feb;37(2):263–6.
    摘要:Fujimoto H, Oyama T, Suito T, Hashimoto K, Kameyama Y, Yasuda H, Ishizuka H. [A case of complete response treated by S-1 with concurrent radiotherapy for a gefitinib-resistant non-small cell lung cancer patient]. Gan To Kagaku Ryoho. 2010 Feb;37(2):295–8.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知